PharVision Advisers’s Blackbaud BLKB Stock Holding History

PharVision Advisers’s Portfolio BLKB Stock Details BLKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,341	Closed	-$279K	–	715
2025 Q3	$279K	Buy	+4,341	New	+$284K	0.16%	268

Other funds holding BLKB

CCG

Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

PharVision Advisers's BLKB Position: Q4 2025 in Review

PharVision Advisers sold out of Blackbaud (BLKB) in Q4 2025, closing a stake of 4,341 shares — an estimated $279K sold.

PharVision Advisers first reported a position in BLKB in Q3 2025 and held it in 1 quarter. The position peaked at $279K in Q3 2025. 303 funds tracked by Wall St. Rank hold BLKB as of Q4 2025.

PharVision Advisers reported no remaining Blackbaud position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 4,341 Blackbaud shares in Q4 2025, an estimated $279K.
PharVision Advisers first reported a position in Blackbaud in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Blackbaud position peaked at $279K in Q3 2025.
303 funds tracked by Wall St. Rank held Blackbaud as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.